Higher prostate cancer risks for black men may warrant new approach to screening

prostate cancer
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia

A new study indicates that higher prostate cancer death rates among black men in the US may be due to a higher risk of developing preclinical prostate cancer as well as a higher risk of that cancer progressing more quickly to advanced stages. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study suggests that screening policies may need to be tailored to the higher-risk status of this population.

Among in the United States, the incidence of prostate is 60 percent higher than that of white men, and their mortality rate from prostate cancer is more than twice as high. To understand why, a team from the Fred Hutchinson Cancer Research Center, the University of Michigan, and Erasmus University in the Netherlands used three models of prostate cancer incidence and (PSA) screening in the United States to estimate disease onset and progression based on prostate cancer data from 1975-2000 reported by the Surveillance, Epidemiology, and End Results program of the National Cancer Institute.

The investigators estimated that 30 percent to 43 percent of black men develop preclinical prostate cancer—prostate cancer that is not symptomatic—by age 85, a risk that is 28 percent to 56 percent higher than that among men of any race.

Among men with preclinical disease, black men have a similar risk of being diagnosed with prostate cancer (35 percent to 49 percent) compared with the (32 percent to 44 percent) in the absence of screening. Their risk of progression to advanced disease by the time they're diagnosed is 44 percent to 75 percent higher than in the general population, however (a 12 to 13 percent risk in black men versus a seven to nine percent risk in the general population).

"We found that the interval from getting preclinical cancer to being diagnosed is long—10 years or more on average—and is similar in black and white men. But during that interval, cancers in black men tend to progress faster," said Dr. Ruth Etzioni, a senior author on the study. "What this means is that in developing screening policies for black men, it will be important to consider beginning screening them at an earlier age and potentially screening them more frequently than would be recommended by general population guidelines." She stressed that additional research is needed to determine the best policies for prostate cancer screening in black men.

In an accompanying editorial, Lauren Wallner, PhD, MPH, of the University of Michigan, and Steven Jacobsen, MD, PhD, of Kaiser Permanente Southern California, noted that the study's findings imply that the risk/benefit trade-offs of PSA screening may be quite different for black men when compared with the general population. "As the evidence is accumulating that a 'one size fits all' screening approach to may not be what is most appropriate, it may be time for the conversation around PSA screening to really focus on more personalized approaches to screening in high-risk black men," they wrote.

Explore further

What men should know about new prostate cancer screening guidelines

More information: Alex Tsodikov et al, Is prostate cancer different in black men? Answers from 3 natural history models, Cancer (2017). DOI: 10.1002/cncr.30687
Journal information: Cancer

Provided by Wiley
Citation: Higher prostate cancer risks for black men may warrant new approach to screening (2017, April 24) retrieved 16 June 2021 from https://medicalxpress.com/news/2017-04-higher-prostate-cancer-black-men.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments